Veradigm Platform Generates Actionable RWE
Veradigm in a recent analysis found that de-identified data from its EHR platform could be used to generate "actionable and [...]
Can Medtech Use Social Media to Generate RWE?
GP and digital RWE advisor Simon Rudland and Orbital Research CEO Peter Brady in a recent interview with Med-Tech Innovation [...]
Addressing a Prominent Health Burden Using Real World Evidence: Management of Heart Failure with Preserved Ejection Fraction
Heart Failure: Common, Debilitating and Growing Public Health Issue Heart failure (HF) is a complex, debilitating syndrome affecting an [...]
Aetion, HealthVerity Launch New Tools for Assessing COVID-19 Treatments
Aetion and HealthVerity have launched a new set of tools for biopharma companies and regulators looking to assess new COVID-19 [...]
Startups Push Forward Despite Pandemic
The COVID-19 pandemic isn't stopping some startups from pushing forward, according to a MedCity News report. According to the report, [...]
HealthCore’s Beachler, Lanes Talk Bolstering RWE with New Tech
In the latest tHEORetically Speaking blog post, HealthCore's Daniel Beachler, Safety & Epidemiology associate director, and Stephen Lanes, Safety & [...]
Predictive Modeling and Machine Learning: Sharpening the Focus of Real-World Evidence in the Age of Precision Medicine
The challenge of real-world evidence in the age of precision medicine Real-world evidence is being used increasingly to provide important [...]
Article Outlines How Health Plans Utilize RWE for Specialty Drug Coverage
Health plans' use of real-world evidence for specialty drug coverage decisions is generally varied in terms of the number and [...]
Webinar – Faster to Market: Transforming HEOR & RWE Using Virtual Sourcing
Wish you could get HEOR & RWE projects started faster, cheaper, & using the most optimal vendor? Do you want [...]
Predictions for RWE in 2020
A recent article published on PharmaTimes looks at what the future may hold for real-world evidence amid rising interest in [...]
RWE 2020 Postponed Until Later This Year
The Real-World Evidence 2020: Rare Diseases and Innovative Therapies event has been postponed to later this year in response to [...]
Opinion: Hub Providers Can Provide ‘Best’ RWE
The pharmaceutical industry's hub and patient-support providers could be the source of the "best" real-world evidence, the author of a [...]
NPC’s Leonard Outlines Findings of Research on Coverage Decisions
National Pharmaceutical Council President and CEO Dan Leonard in a recent write up published on Pharmacy Times outlines some key [...]
Tackling Rare Diseases with an Arsenal of Real-World Data
Technological innovations have fostered the age of big data in healthcare – and the huge populations amassed afford the ability to mine for key subpopulations -- getting down to ever more precise groups of likely responders to therapy, high-risk patients and other high-value subphenotypes.
Social Determinants of Health: When Health Care is More Than Just Medicine
CMS projects that national health spending in the United States (US) will reach almost $6 trillion by 2027. Can a focus on social risk improve health and moderate skyrocketing costs?
ICER Announces RWE Partnership with Aetion
The Institute for Clinical and Economic Review (ICER) is partnering with Aetion to "generate decision-grade real-world evidence," the drug pricing [...]
COTA White Paper Spotlights Perspectives on RWE
A new white paper from COTA offers unique perspectives on real-world evidence (RWE), including input from Pfizer and Bristol-Myers Squibb [...]
Randomization vs. Real-World Evidence
Nonrandomized observational studies have been touted by some as being a viable alternative to randomized clinical trials, but are they [...]
New RWE Company Partnering with Medical Societies for Data
A new real-world evidence company, Verana Health, is partnering with medical societies to obtain data for research in eye disease [...]
NICE Looks to Include EHRs, RWE in Guidance
The U.K.'s National Institute for Health and Care Excellence (NICE) announced plans to incorporate electronic health records and real-world evidence [...]
Report: ICER to Assess RWE on Accelerated Approvals
The Institute for Clinical and Economic Review (ICER) will incorporate real-world evidence into future updates of already-reviewed according to a [...]
Optimizing Real-World Evidence in Medical Device Development
The use of real-world data to generate RWE for medical devices by industry has become more prominent in recent years, and more attractive to a variety of stakeholders. It is used frequently to understand the use of the device in the larger clinical setting, but more recently it is also being used for regulatory decision making.
Survey Finds Increasing Interest in Patient-Reported Data from Outcomes-Based Contracts
A new survey conducted by Avalere Health suggests rising interest among payers to generate patient-reported data through outcomes-based contracts, according [...]
Page Talks Patient-Centered Pathways, RWE, AI
Center for Cancer and Blood Disorders President and Director of Research Ray Page in a recent podcast posted on the [...]
Article Reflects on FDA’s Moves in Last Decade
A recent article by The Pink Sheet takes a step back to highlight how the Food and Drug Administration (FDA) [...]
